DNA Methylation Study in Colorectal Cancer
Author Information
Author(s): Kibriya Muhammad G, Raza Maruf, Jasmine Farzana, Roy Shantanu, Paul-Brutus Rachelle, Rahaman Ronald, Dodsworth Charlotte, Rakibuz-Zaman Muhammad, Kamal Mohammed, Ahsan Habibul
Primary Institution: The University of Chicago
Hypothesis
The study aims to identify differentially methylated loci in colorectal carcinoma using a genome-wide scan.
Conclusion
The study found a large number of novel differentially methylated loci in colorectal carcinoma tissue, which may have potential clinical applications.
Supporting Evidence
- 627 differentially methylated loci were identified in colorectal carcinoma.
- 535 of the identified loci were novel.
- Gene Set Enrichment Analysis revealed significant hypermethylation in specific gene sets related to cancer.
Takeaway
Researchers looked at DNA changes in cancer samples and found many new markers that could help doctors in the future.
Methodology
The study used Illumina's Infinium methylation assay on paired DNA samples from colorectal cancer tissues and normal colon tissues.
Potential Biases
Potential bias due to the use of a single medical center for sample collection.
Limitations
The study was limited to a small sample size and did not validate findings in an independent cohort.
Participant Demographics
24 patients (17 male, 7 female) with a mean age of 45.5 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 27,488 - 27,534
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website